These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24853998)

  • 41. Triglyceride to high-density lipoprotein cholesterol ratio is associated with increased mortality in older patients on peritoneal dialysis.
    Zhan X; Yang M; Zhou R; Wei X; Chen Y; Chen Q
    Lipids Health Dis; 2019 Nov; 18(1):199. PubMed ID: 31729985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study.
    Inonu Koseoglu H; Pazarli AC; Kanbay A; Demir O
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):139-144. PubMed ID: 27837155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-density lipoprotein cholesterol and causes of death in chronic kidney disease.
    Navaneethan SD; Schold JD; Walther CP; Arrigain S; Jolly SE; Virani SS; Winkelmayer WC; Nally JV
    J Clin Lipidol; 2018; 12(4):1061-1071.e7. PubMed ID: 29699917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease.
    Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
    Ann Med; 2012 May; 44(3):262-70. PubMed ID: 21114460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Association of dp-ucMGP with Cardiovascular Morbidity and Decreased Renal Function in Diabetic Chronic Kidney Disease.
    Roumeliotis S; Roumeliotis A; Stamou A; Leivaditis K; Kantartzi K; Panagoutsos S; Liakopoulos V
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
    Skali H; Uno H; Levey AS; Inker LA; Pfeffer MA; Solomon SD
    Am Heart J; 2011 Sep; 162(3):548-54. PubMed ID: 21884875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
    Shishehbor MH; Oliveira LP; Lauer MS; Sprecher DL; Wolski K; Cho L; Hoogwerf BJ; Hazen SL
    Am J Cardiol; 2008 Jun; 101(12):1741-6. PubMed ID: 18549850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
    Dai W; Zhang Z; Zhao S
    Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutual effect modification between adiponectin and HDL as risk factors of cardiovascular events in Type 2 diabetes individuals: a cohort study.
    Roumeliotis S; Liakopoulos V; Roumeliotis A; Stamou A; Panagoutsos S; D'Arrigo G; Tripepi G
    Int Urol Nephrol; 2021 Dec; 53(12):2583-2591. PubMed ID: 33674951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Hovingh GK; Mora S; Pedersen TR; Larosa JC; Welch KM; Amarenco P; Demicco DA; Tonkin AM; Sullivan DR; Kirby A; Colhoun HM; Hitman GA; Betteridge DJ; Durrington PN; Clearfield MB; Downs JR; Gotto AM; Ridker PM; Kastelein JJ
    Circulation; 2013 Oct; 128(14):1504-12. PubMed ID: 23965489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.
    Ganda A; Magnusson M; Yvan-Charvet L; Hedblad B; Engström G; Ai D; Wang TJ; Gerszten RE; Melander O; Tall AR
    Circulation; 2013 Mar; 127(9):988-96. PubMed ID: 23378299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real-World Administrative Claims Analysis of Statin-Treated Patients With High Residual Cardiovascular Risk.
    Toth PP; Granowitz C; Hull M; Liassou D; Anderson A; Philip S
    J Am Heart Assoc; 2018 Aug; 7(15):e008740. PubMed ID: 30371242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.